Ethical Compliance
CAPLIN POINT LAB.
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Market Cap Class:
large
Revenue
2.8%
Debt
0%
Liquidity
20.5%
Revenue
Debt
Liquidity
2.8%
Non Compliant
Questionable
Compliant
Compliant
INR Crores
| Export Incentives | ₹17.32 |
| Other Income | ₹16.86 |
| Sales of Service | ₹75.23 |
| Pharmaceuticals | ₹1,601.55 |
Questionable
INR Crores
| Investment Gain | ₹2.90 |
Non Compliant
INR Crores
| Interest Income | ₹47.28 |
INR Crores
| Revenue from Questionable Sources: | ₹2.90 |
| Revenue from Non Compliant Sources: | ₹47.28 |
| Total: | ₹50.18 |
| Total Revenue: | ₹1,761.04 |
Formula
Revenue from Questionable & Non Compliant Sources
Total Revenue
≤ 0.03 or 3%
Calculation
₹50.18
₹1,761.04
= 2.8%
compliant
Rationale
The sum of revenue from questionable and non-compliant sources should not exceed 3% of the total revenue. This ensures that the company has tolerable reliance on unethical sources of revenue.
